Muscle-Targeted Promoters

About Syngensys

Syngensys is a private, pre-revenue biotech company applying synthetic biology and machine learning to solve critical gene expression challenges in advanced therapies and industrial bioproduction. Its core offering is the 'Sypher' platform, which uses deep learning on transcriptional data to design novel synthetic promoters and other genetic components for specific therapeutic or manufacturing applications. The company operates a hybrid business model, offering both off-the-shelf promoter products for areas like liver, muscle, and NK cell therapies, as well as custom design and development services for biopharma partners. Headquartered in Cambridge, UK, with an operational office in Sheffield, Syngensys is positioned at the intersection of AI-driven drug discovery and the rapidly growing cell & gene therapy market.

Therapeutic Areas